We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · July 03, 2022

Effect of Diabetes Medications and Glycemic Control on Risk of HCC in Patients With NAFLD

Hepatology (Baltimore, Md.)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Hepatology (Baltimore, Md.)
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
Hepatology 2022 Jun 01;75(6)1420-1428, JR Kramer, Y Natarajan, J Dai, X Yu, L Li, HB El-Serag, F Kanwal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading